Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,930
Closed -$34K 118
2024
Q1
$34K Buy
2,930
+800
+38% +$10.6K 0.01% 119
2023
Q4
$35.3K Hold
2,130
0.01% 118
2023
Q3
$48.1K Sell
2,130
-209
-9% -$5.93K 0.01% 112
2023
Q2
$74.8K Sell
2,339
-44
-2% -$1.41K 0.02% 100
2023
Q1
$71.1K Buy
2,383
+61
+3% +$2.58K 0.02% 104
2022
Q4
$109K Buy
2,322
+891
+62% +$45.3K 0.03% 101
2022
Q3
$58K Hold
1,431
0.02% 103
2022
Q2
$54K Hold
1,431
0.01% 100
2022
Q1
$69K Buy
1,431
+16
+1% +$865 0.02% 102
2021
Q4
$89K Buy
1,415
+65
+5% +$5.13K 0.02% 103
2021
Q3
$139K Buy
1,350
+275
+26% +$31.1K 0.04% 101
2021
Q2
$116K Buy
1,075
+127
+13% +$9.52K 0.03% 100
2021
Q1
$51K Buy
948
+128
+16% +$9.25K 0.01% 102
2020
Q4
$51K Hold
820
0.01% 106
2020
Q3
$64K Buy
820
+127
+18% +$9.88K 0.02% 100
2020
Q2
$53K Hold
693
0.02% 100
2020
Q1
$33K Buy
+693
New +$43.5K 0.01% 97

Other funds holding AGEN

Lynch & Associates's AGEN Position: Q2 2024 in Review

Lynch & Associates sold out of Agenus (AGEN) in Q2 2024, closing a stake of 2,930 shares — an estimated $34K sold.

Lynch & Associates first reported a position in AGEN in Q1 2020 and held it in 17 quarters. The position peaked at $139K in Q3 2021. 89 funds tracked by Wall St. Rank hold AGEN as of Q2 2024.

  • Lynch & Associates reported no remaining Agenus position as of Q2 2024 after selling out during the quarter.
  • Lynch & Associates sold 2,930 Agenus shares in Q2 2024, an estimated $34K.
  • Lynch & Associates first reported a position in Agenus in Q1 2020 and held it in 17 quarters.
  • Lynch & Associates's Agenus position peaked at $139K in Q3 2021.
  • 89 funds tracked by Wall St. Rank held Agenus as of Q2 2024.

Based on Lynch & Associates's 13F filing for Q2 2024, filed 6 Aug 2024.